PNC Financial Services Group
HELX icon

PNC Financial Services Group’s Franklin Genomic Advancements ETF HELX Stock Holding History

PNC Financial Services Group’s Portfolio HELX Stock Details HELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30
Closed -$1K – 4806
2022
Q3 		$1K Hold
30
– – ﹤0.01% 4315
2022
Q2 		$1K Buy
+30
New +$990 ﹤0.01% 4338

Other funds holding HELX

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BFEC
Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group's HELX Position: Q4 2022 in Review

PNC Financial Services Group sold out of Franklin Genomic Advancements ETF (HELX) in Q4 2022, closing a stake of 30 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in HELX in Q2 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 9 funds tracked by Wall St. Rank hold HELX as of Q4 2022.

  • PNC Financial Services Group reported no remaining Franklin Genomic Advancements ETF position as of Q4 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 30 Franklin Genomic Advancements ETF shares in Q4 2022, an estimated $1K.
  • PNC Financial Services Group first reported a position in Franklin Genomic Advancements ETF in Q2 2022 and held it in 2 quarters.
  • PNC Financial Services Group's Franklin Genomic Advancements ETF position peaked at $1K in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Franklin Genomic Advancements ETF as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.